CollPlant Biotechnologies Ltd (CLGN)
5.41
+0.01
(+0.19%)
USD |
NASDAQ |
Apr 24, 16:00
CollPlant Biotechnologies Cash from Financing (TTM): 1.108M for Dec. 31, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 1.108M |
September 30, 2023 | 1.508M |
June 30, 2023 | 1.292M |
March 31, 2023 | 1.203M |
December 31, 2022 | 1.874M |
September 30, 2022 | 1.616M |
June 30, 2022 | 3.363M |
March 31, 2022 | 4.721M |
December 31, 2021 | 38.76M |
September 30, 2021 | 38.61M |
June 30, 2021 | 36.88M |
March 31, 2021 | 35.47M |
December 31, 2020 | 4.465M |
September 30, 2020 | 4.465M |
June 30, 2020 | 9.883M |
March 31, 2020 | 9.94M |
Date | Value |
---|---|
December 31, 2019 | 5.41M |
September 30, 2019 | 5.325M |
June 30, 2019 | 1.202M |
March 31, 2019 | 2.218M |
December 31, 2018 | 2.753M |
September 30, 2018 | 7.056M |
June 30, 2018 | 7.692M |
March 31, 2018 | 7.764M |
December 31, 2017 | 9.106M |
September 30, 2017 | 4.771M |
June 30, 2017 | 2.954M |
March 31, 2017 | 4.716M |
December 31, 2016 | 4.806M |
September 30, 2016 | 4.946M |
June 30, 2016 | 7.363M |
March 31, 2016 | 4.517M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
1.108M
Minimum
Dec 2023
38.76M
Maximum
Dec 2021
10.90M
Average
4.465M
Median
Sep 2020
Cash from Financing (TTM) Benchmarks
Compugen Ltd | -- |
Pluri Inc | -- |
BioLine Rx Ltd | 15.06M |
Can Fite Biofarma Ltd | -- |
BiomX Inc | 2.899M |